Given the role of PDGFRB in cancer, a plethora of PDGF/PDGFR pathway inhibitors are available and assayed in clinical trials for leukemia, gastrointestinal stromal tumors (GIST), and glioma (https://clinicaltrials.gov/). Here, PDGFRB is linked to central nervous system cancer.